Fraunhofer-Institut für Zelltherapie und Immunologie (IZI)

Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity (2024) Herrmann A, Gege C, Wangen C, Wagner S, Kögler M, Cordsmeier A, Irrgang P, et al. Journal article Influence of AAV vector tropism on long-term expression and Fc-γ receptor binding of an antibody targeting SARS-CoV-2 (2024) Wagner J, Müller-Schmucker S, Wang W, Arnold P, Uhlig N, Issmail L, Eberlein V, et al. Journal article Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model (2024) Stahl-Hennig C, Peter AS, Cordsmeier A, Stolte-Leeb N, Vestweber R, Socher E, Merida SA, et al. Journal article Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis (2024) Köppen J, Kleinschmidt M, Morawski M, Rahfeld JU, Wermann M, Cynis H, Hegenbart U, et al. Journal article Interdisciplinary studies on Coxiella burnetii: From molecular to cellular, to host, to one health research (2023) Bauer BU, Knittler MR, Andrack J, Berens C, Campe A, Christiansen B, Fasemore AM, et al. Journal article, Review article A lipid membrane supported on an artificial extracellular matrix made of polyelectrolyte multilayers: towards nanoarchitectonics at the cellular interface (2022) Vikulina A, Wulf A, Guday G, Fakhrullin R, Volodkin D Journal article Alpha synuclein processing by MMP-3 – implications for synucleinopathies (2022) Bluhm A, Schrempel S, Moceri S, Stieler J, Feja M, Schilling S, Schulze A, et al. Journal article Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization (2022) Lapuente D, Fuchs J, Willar J, Antao A, Eberlein V, Uhlig N, Issmail L, et al. Conference contribution Immunohistochemical Demonstration of the pGlu79 alpha-Synuclein Fragment in Alzheimer's Disease and Its Tg2576 Mouse Model (2022) Bluhm A, Schrempel S, Schilling S, von Hörsten S, Schulze A, Rossner S, Hartlage-Ruebsamen M Journal article Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside? (2022) Guedan S, Luu M, Ammar D, Barbao P, Bonini C, Bousso P, Buchholz CJ, et al. Journal article, Review article